Advertisement

Topics

Promius Pharma, LLC Company Profile

03:53 EST 19th November 2017 | BioPortfolio

Promius Pharma, located in Bridgewater, NJ, is a branded specialty company and a wholly-owned subsidiary of Dr. Reddy’s Laboratories, Inc. Promius Pharma, with its focus on the branded dermatology market, has a portfolio of in-licensed dermatological products and an internal pipeline of topical products under various stages of development. Promius Pharma aims to be a leading-edge company that develops and markets innovative solutions for challenging dermatological conditions with an eye to the future to redefine therapeutic options for physicians and patients. (www.promiuspharma.com)


News Articles [566 Associated News Articles listed on BioPortfolio]

Promius Pharma Named PM360 Trailblazer 2017 Company of the Year for Specialty Pharma/Biotech ...

"We are delighted that PM360is recognizing the exceptional work of our neurology marketing team, and Promius Pharma as a company of the year finalist," Read more...

Promius’s sumatriptan meets primary endpoint for migraine

Dr. Reddy’s Laboratories’ subsidiary Promius Pharma has reported positive results from the clinical trial of its ZEMBRACE SymTouch (sumatriptan injection)...Read More... The post Promius’s sumat...

Promius Pharma, LLC Presents Positive Results For Phase II Study Of DFN-02, A Novel Intranasal Formulation Of Sumatriptan, At

  Life Sciences Jobs   ...

Encore Dermatology gets rights to psoriasis drug DFD-06

Dr Reddy’s Laboratories, through its wholly-owned US subsidiary Promius Pharma, has out-licensed the…

Promius Pharma Named PM360 Silver Winner Trailblazer Specialty Pharma/Biotech Company of the Year

PRINCETON, N.J., Sept. 26, 2017 /PRNewswire/ -- PM360, a publication for marketing decision makers in the pharma/biotech and medical device industries, has named Promius Pharma the Silver Wi...

Promius Pharma Presents Positive Results for Phase 2 Study of DFN-02, a Novel Intranasal Formulation of Sumatriptan, at 18th Congress of the International Headache Society

PRINCETON, N.J., Sept. 7, 2017 /PRNewswire/ -- Promius Pharma, LLC will present the previously announced (June 7, 2017) primary endpoint results of its Phase 2 study of DFN-02, a novel intranasal suma...

Promius Pharma Announces ZEMBRACE® SymTouch® (Sumatriptan Injection) 3 mg Achieves Primary ...

Overall, the trial found that a significantly higher proportion of subjects experienced migraine pain freedom at 2 hours postdose with ZEMBRACE SymTouch compared with placebo: Read more...

Promius Pharma to Present 3 Posters, Including a Podium Presentation, from MAST Study--the Largest Online Longitudinal Epidemiological Survey of Episodic/Chronic Migraine in the United States

PRINCETON, N.J., Sept. 7, 2017 /PRNewswire/ -- Promius Pharma LLC announced today that it is presenting 3 posters, including a podium presentation, from the 2017 Migraine in America Symptoms and Treat...

Drugs and Medications [238 Associated Drugs and Medications listed on BioPortfolio]

Cloderm [Promius Pharma, LLC]

Cloderm Cream, 0.1% (clocortolone pivalate)

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Urea [Libertas Pharma, Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

PubMed Articles [23 Associated PubMed Articles listed on BioPortfolio]

Delivering advanced therapies: The big pharma approach.

After two decades of focused development and some recent clinical successes, cell and gene therapy (CGT) is emerging as a promising approach to personalized medicines. Genetically engineered cells as ...

Bioanalytical outsourcing: transitioning from Pharma to CRO.

AI-powered drug discovery captures pharma interest.

Clinical Trials Series - Large Pharma.

Arkansas execution proceeds as pharma companies lose battle to stop use of their drugs.

Clinical Trials [75 Associated Clinical Trials listed on BioPortfolio]

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...

A Bio-equivalence Study of Sofosbuvir From Sofodelevier 400 mg Film Coated Tablets (Al-debeiky Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada)

Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir from Sofodelevier 400...

To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions

To demonstrate the relative bioavailability of Cilostazol 50 mg tablets under fasting conditions.

Companies [725 Associated Companies listed on BioPortfolio]

Promius Pharma, LLC

Promius Pharma, located in Bridgewater, NJ, is a branded specialty company and a wholly-owned subsidiary of Dr. Reddy’s Laboratories, Inc. Promius Pharma, with its focus on t...

Foamix Ltd

Foamix Ltd. is a leading developer of topical and mucosal foams for dermatological and gynecological applications. Foamix's state-of-the-art foams provide controlled delivery of a variety of activ...

H3 Pharma Incorporated

H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and ...

LEO Pharma Inc.

LEO Pharma Inc. is headquartered in Parsippany, New Jersey, and is the U.S. affiliate of Denmark-based LEO Pharma A/S, a global leader in dermatology and critical care with more t...

Laurantis Pharma Oy

Laurantis Pharma Oy is a privately held specialty pharmaceutical company based in Finland. Laurantis Pharma Oy was formed in 2010 through the merger of two independent companies, ...

More Information about "Promius Pharma, LLC" on BioPortfolio

We have published hundreds of Promius Pharma, LLC news stories on BioPortfolio along with dozens of Promius Pharma, LLC Clinical Trials and PubMed Articles about Promius Pharma, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Promius Pharma, LLC Companies in our database. You can also find out about relevant Promius Pharma, LLC Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record